|
|
|
|
|
|
|
|
abstract/partial view
This Viewpoint
considers 3 nuances of the policy debate regarding the regionalization
of high-risk surgery by restricting care to high-volume centers of
excellence.
Regionalizing
high-risk surgery by restricting care to high-volume centers of
excellence is a quality-improvement strategy with intuitive appeal.
Decades of research have shown that the highest-volume hospitals have
better outcomes for major surgery.1
Accordingly, 3 prominent medical centers—Dartmouth-Hitchcock Medical
Center, Johns Hopkins Medicine, and the University of Michigan—recently
announced a “volume pledge” to restrict their own facilities and
surgeons from performing any of 10 selected procedures unless they meet
volume criteria.2,3
Apart from a voluntary pledge, other policy approaches to
regionalization have included the refusal to reimburse low-volume
facilities (as Medicare currently does for solid-organ transplants) and
tiered insurance benefits (ie, reducing out-of-pocket payments at
high-volume hospitals).
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.